These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation. Yang K; Chen Y; Qi H; Ye Y; Fan Z; Huang F; Zhang H; Suo Y; Liu Q; Jin H Front Immunol; 2020; 11():1505. PubMed ID: 32849514 [TBL] [Abstract][Full Text] [Related]
6. Tissue Renin-Angiotensin System in Lacrimal Gland Fibrosis in a Murine Model of Chronic Graft-Versus-Host Disease. Yaguchi S; Ogawa Y; Kawakita T; Shimmura S; Tsubota K Cornea; 2015 Nov; 34 Suppl 11():S142-52. PubMed ID: 26448172 [TBL] [Abstract][Full Text] [Related]
7. Antimitochondrial antibodies in patients with chronic graft-versus-host disease. Siegert W; Stemerowicz R; Hopf U Bone Marrow Transplant; 1992 Sep; 10(3):221-7. PubMed ID: 1422476 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of autoantibody expression in allogeneic stem-cell recipients. Moon JH; Lee SJ; Kim JG; Chae YS; Kim SN; Kang BW; Suh JS; Lee KS; Sohn SK Transplantation; 2009 Jul; 88(2):242-50. PubMed ID: 19623021 [TBL] [Abstract][Full Text] [Related]
9. Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity. Jachiet M; de Masson A; Peffault de Latour R; Rybojad M; Robin M; Bourhis JH; Xhaard A; Dhedin N; Sicre de Fontbrune F; Suarez F; Barete S; Parquet N; Nguyen S; Ades L; Rubio MT; Wittnebel S; Bagot M; Socié G; Bouaziz JD Br J Dermatol; 2014 Jul; 171(1):63-8. PubMed ID: 24404963 [TBL] [Abstract][Full Text] [Related]
10. [Association of the ratio of regulatory and effector T cells with recurrence and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation]. Wang HT; Zhao XY; Zhao XS; Han TT; Lv M; Chang YJ; Huang XJ Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):679-84. PubMed ID: 23978019 [TBL] [Abstract][Full Text] [Related]
11. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant. Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658 [TBL] [Abstract][Full Text] [Related]
12. Potential value of autoantibodies as biomarkers of chronic graft-versus-host disease after allogeneic stem cell transplantation. Hao B; Gao S; Sang YW; Wang L; Meng XQ; You JY J Zhejiang Univ Sci B; 2019 Oct.; 20(10):849-860. PubMed ID: 31489804 [TBL] [Abstract][Full Text] [Related]
13. Anti-angiotensin II type 1 receptor autoantibodies (AT İlgen U; Yayla ME; Düzgün N Rheumatol Int; 2017 Apr; 37(4):593-598. PubMed ID: 28004166 [TBL] [Abstract][Full Text] [Related]
14. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis. Budding K; van de Graaf EA; Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Dragun D; Hack CE; Otten HG J Cyst Fibros; 2015 Jan; 14(1):42-5. PubMed ID: 25096855 [TBL] [Abstract][Full Text] [Related]
15. Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease. Pastano R; Dell'Agnola C; Bason C; Gigli F; Rabascio C; Puccetti A; Tinazzi E; Cetto G; Peccatori F; Martinelli G; Lunardi C Int Immunol; 2012 Sep; 24(9):583-91. PubMed ID: 22773152 [TBL] [Abstract][Full Text] [Related]
16. Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease. Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D Transplantation; 2008 Jun; 85(12):1826-32. PubMed ID: 18580477 [TBL] [Abstract][Full Text] [Related]
17. Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Martin SJ; Audrain MA; Oksman F; Ecoiffier M; Attal M; Milpied N; Esnault VL Bone Marrow Transplant; 1997 Jul; 20(1):45-8. PubMed ID: 9232255 [TBL] [Abstract][Full Text] [Related]
19. High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT. Urbano-Ispizua A; García-Conde J; Brunet S; Hernández F; Sanz G; Petit J; Bargay J; Figuera A; Rovira M; Solano C; Ojeda E; de la Rubia J; Rozman C Haematologica; 1997; 82(6):683-9. PubMed ID: 9499667 [TBL] [Abstract][Full Text] [Related]
20. Incidence and prognostic value of eosinophilia in chronic graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation. Ahmad I; Labbé AC; Chagnon M; Busque L; Cohen S; Kiss T; Lachance S; Roy DC; Sauvageau G; Roy J Biol Blood Marrow Transplant; 2011 Nov; 17(11):1673-8. PubMed ID: 21601640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]